Results 251 to 260 of about 36,124 (280)

Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer

Nature, 2022
Cameron Herberts, Matti Annala, Joonatan Sipola   +2 more
exaly  

ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper

Nature Reviews Clinical Oncology, 2020
Arvind Dasari, Van K Morris, Carmen J Allegra   +2 more
exaly  

ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results

Nature Medicine, 2023
Valsamo Anagnostou, Benjamin Levy, Noushin Niknafs   +2 more
exaly  

ctDNA prognostiziert Therapieansprechen

Gastro-News
Alexis Wilhelm, Florian Scheufele, Helmut Friess   +2 more
openaire   +1 more source

When can we be confident of surgical cure with ctDNA?

Nature Reviews Clinical Oncology, 2022
exaly  

MOLECULAR CLUSTERING ON CTDNA IMPROVES THE PROGNOSTIC STRATIFICATION OF DLBCL PATIENTS COMPARED TO CTDNA LEVELS

Hematological Oncology, 2023
R. Moia, D. Talotta, R. Dondolin, M. Almasri, C. Cosentino, R. Bruna, I. Della Starza, R. Soscia, A. Bruscaggin, L. Terzi Di Bergamo, A. Andorno, F. Mercalli, R. Bomben, T. Bittolo, F. Vit, P. Bulian, F. Melle, G. Motta, M. Leutner, A. M. Mahmoud, C. Deambrogi, S. Rasi, D. Faraci, S. Mouhssine, L. Petrucci, R. L. Boldorini, A. Di Rocco, I. Del Giudice, M. Spina, V. Canzonieri, M. Martelli, S. Pileri, V. Gattei, D. Rossi, R. Foà, G. Gaidano   +35 more
openaire   +1 more source

New data confirm clinical utility of ctDNA

Nature Reviews Clinical Oncology, 2022
openaire   +2 more sources

ctDNA

2008
openaire   +1 more source

CTCs/ctDNA and Brain Metastasis

2022
S. Ray Kenney, Dario Marchetti
openaire   +1 more source

Early stage NSCLC — challenges to implementing ctDNA-based screening and MRD detection

Nature Reviews Clinical Oncology, 2018
Christopher Abbosh, Nicolai J Birkbak, Charles Swanton   +2 more
exaly